Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of ranirestat in diabetic peripheral neuropathy
jRCT2080221660Phase 3
- Sponsor
- Sumitomo Pharma
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic polyneuropathy (DPN) comparing Ranirestat 40 mg with Placebo (2 arms).
02
Drugs
ranirestat
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on jRCT2080221660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221660.